Human BCA1(CXCL13) Recombinant
Catalog #
90104-A
$130
*
●
●
Purchase
Description
Recombinant human BCA1 (B cell- attracting chemokine 1), also known as CXCL13 or BLC, is a disulfide-linked monomeric protein consisting of 88 a.a. and migrates as an approximately 10 kDa protein under reducing and non-reducing conditions. Human CXCL13, generated by the proteolytic removal of the signal peptide and propeptide, has a calculated molecular mass of ~10 kDa. Optimized DNA sequence encoding human BCA1 mature domain was expressed in E. coli.
●
Synonyms
BCA1, B cell- attracting chemokine 1, CXCL13, BLC
Product Info
Storage and Usage
Citations
Species
Human
Host Species/Expression System
E. coli
Purity
≥98% by SDS-PAGE and HPLC
Format
lyophilized protein
Formulation
Lyophilized from a 0.2 µm filtered solution containing 20 mM phosphate buffer, pH 7.5, 100 mM NaCl.
MW
10 kDa
Endotoxin Level
Endotoxin level was found to be < 0.1 ng/μg (1EU/μg), using the LAL gel clot method.
Amino Acids
23–109
Amino Acid Sequence
VLEVYYTS LRCRCVQESS VFIPRRFIDR IQILPRGNGC PRKEIIVWKK NKSIVCVDPQ AEWIQRMMEV LRKRSSSTLP VPVFKRKIP
Biological Activity
Determined by its ability to chemoattract human CXCR5 transfected mouse BaF3 B cells with ED50 >20 ng/ml.
Genbank #
Q53X90
UniProt #
Q53X90
Background
The homeostatic chemokine CXCL13 (also called B cell- attracting chemokine 1 [BCA- 1] or B-lymphocyte chemoattractant [BLC]) is constitutively expressed in secondary lymphoid tissue and initiates lymphoid neogenesis when expressed aberrantly in mice. CXCL13 has also been detected in chronic inflammation associated with human lymphoid neogenesis, suggesting a pathogenic role. Follicular dendritic cells (FDCs) are generally considered to be the major source of CXCL13 both in normal and aberrant lymphoid tissue. CXCL13 has been the exclusive ligand for CXCR5, which initiates chemotaxis toward an increasing gradient in vitro and to B cell zones in lymph nodes that express CXCL13. More recently, CXCR5 expression has also been shown in DN T cells in mice, a subset of CD4 follicular Th cells, and some tonsillar CD4+CD25+ Treg cells in humans.
References
1. Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS. Neurology, Dec 2009, 73: 2003 - 2010.
2. B-cell-attracting chemokine CXCL13 as a marker of disease activity and renal involvement in systemic lupus erythematosus (sle). Nephrol. Dial. Transplant., Dec 2009, 24: 3708 - 3712.
2. B-cell-attracting chemokine CXCL13 as a marker of disease activity and renal involvement in systemic lupus erythematosus (sle). Nephrol. Dial. Transplant., Dec 2009, 24: 3708 - 3712.
Powered by Bioz
6405 Mira Mesa Blvd. Suite 100
San Diego, CA 92121
858-202-1401
San Diego, CA 92121
858-202-1401
Products are for Research Use Only
COMPANY
Copyright © 2024
BPS Bioscience, Inc.
All rights reserved.
Diagrams on this website are created with BioRender.com.